Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,585.00
-105.00 (-2.85%)
At close: Mar 19, 2026
Market Cap79.25B -1.3%
Revenue (ttm)108.41B +11.4%
Net Income3.67B +3,670.1%
EPS146.00 +2,067.6%
Shares Out21.74M
PE Ratio24.97
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume32,511
Average Volume61,710
Open3,670.00
Previous Close3,690.00
Day's Range3,570.00 - 3,670.00
52-Week Range3,200.00 - 5,090.00
Beta0.50
RSI47.87
Earnings DateMar 24, 2026

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2024, KOSDAQ:142280's revenue was 103.85 billion, an increase of 10.47% compared to the previous year's 94.01 billion. Earnings were 3.58 billion, an increase of 99.25%.

Financial Statements